It is truly an honor to be able to collaborate with the team at Biohaven on this exciting journey." BHV-1300 is differentiated from monoclonal antibodies targeting FcRn inhibition, offering a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback